文献
J-GLOBAL ID:202102263000630510
整理番号:21A0293095
REV7の標的化は結腸直腸癌において5-FUとオキサリプラチン耐性を効果的に逆転する【JST・京大機械翻訳】
Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer
著者 (6件):
Sun Xianjun
(Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academic Sciences, Jinan, China)
,
Hou Wenhou
(Department of Radiotherapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academic Sciences, Jinan, China)
,
Liu Xin
(Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academic Sciences, Jinan, China)
,
Chai Jie
(Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academic Sciences, Jinan, China)
,
Guo Hongliang
(Department of Gastrointestinal Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academic Sciences, Jinan, China)
,
Yu Jinming
(Department of Radiotherapy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academic Sciences, Jinan, China)
資料名:
Cancer Cell International (Web)
(Cancer Cell International (Web))
巻:
20
号:
1
ページ:
1-12
発行年:
2020年
JST資料番号:
U7315A
ISSN:
1475-2867
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)